HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Christoph Wagener Selected Research

CEACAM1 Protein

10/2018CEACAM1 in Liver Injury, Metabolic and Immune Regulation.
1/2018CEACAM1 promotes melanoma metastasis and is involved in the regulation of the EMT associated gene network in melanoma cells.
9/2016CEACAM1 controls the EMT switch in murine mammary carcinoma in vitro and in vivo.
11/2014CEACAM1 confers resistance toward oxygen-induced vessel damage in a mouse model of retinopathy of prematurity.
9/2013Carcinoembryonic antigen-related cell adhesion molecule 1 inhibits MMP-9-mediated blood-brain-barrier breakdown in a mouse model for ischemic stroke.
11/2012Acceleration of collateral development by carcinoembryonic antigen-related cell adhesion molecule 1 expression on CD11b/⁺Gr-1⁺ myeloid cells--brief report.
5/2010Osteopontin (OPN) expression in thyroid carcinoma.
7/2009CEACAM1 expression in pancreatic endocrine tumors.
6/2009CEACAM1+ myeloid cells control angiogenesis in inflammation.
2/2009Magnetic resonance imaging of melanoma metastases in a clinical relevant human melanoma xenograft scid mouse model.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Christoph Wagener Research Topics

Disease

22Neoplasms (Cancer)
01/2020 - 02/2002
8Neoplasm Metastasis (Metastasis)
01/2020 - 05/2002
7Carcinoma (Carcinomatosis)
09/2016 - 02/2002
5Breast Neoplasms (Breast Cancer)
01/2019 - 02/2002
4Inflammation (Inflammations)
10/2018 - 03/2006
4Melanoma (Melanoma, Malignant)
01/2018 - 05/2002
4Adenocarcinoma
09/2016 - 03/2006
3Vascular Remodeling
11/2014 - 06/2006
2Pancreatic Neoplasms (Pancreatic Cancer)
05/2015 - 12/2014
2Arterial Occlusive Diseases (Arterial Occlusive Disease)
11/2012 - 06/2006
2Ischemia
11/2012 - 06/2006
2Colorectal Neoplasms (Colorectal Cancer)
06/2007 - 03/2004
1Circulating Neoplastic Cells
01/2020
1Fibrosis (Cirrhosis)
10/2018
1Insulin Resistance
10/2018
1Non-alcoholic Fatty Liver Disease
10/2018
1Liver Diseases (Liver Disease)
10/2018
1Obesity
10/2018
1Alcoholic Fatty Liver
10/2018
1Exocrine Pancreatic Insufficiency
10/2018
1Infections
03/2015
1Hypoxia (Hypoxemia)
11/2014
1Retinal Neovascularization
11/2014
1Retinopathy of Prematurity (Retrolental Fibroplasia)
11/2014
1Stroke (Strokes)
09/2013
1Ischemic Stroke
09/2013
1Atrophy
09/2013
1Brain Ischemia (Cerebral Ischemia)
09/2013
1Edema (Dropsy)
09/2013
1Reperfusion Injury
09/2013
1Peritoneal Neoplasms
05/2013
1Hemolysis
10/2011
1Thyroid Neoplasms (Thyroid Cancer)
05/2010
1Papillary Carcinoma
05/2010
1Cutaneous Leishmaniasis
06/2009
1Lymphatic Metastasis
06/2007
1Neoplasm Micrometastasis
06/2007
1Nevus (Nevi)
04/2007
1Autoimmune Diseases (Autoimmune Disease)
03/2006
1Endometrial Neoplasms (Endometrial Cancer)
03/2006

Drug/Important Bio-Agent (IBA)

20CEACAM1 ProteinIBA
10/2018 - 02/2002
7Cell Adhesion MoleculesIBA
04/2012 - 02/2002
6Proteins (Proteins, Gene)FDA Link
05/2015 - 02/2002
5Polysaccharides (Glycans)IBA
01/2020 - 12/2014
5LigandsIBA
01/2020 - 04/2012
4Glycoproteins (Glycoprotein)IBA
05/2015 - 12/2010
3Biological ProductsIBA
01/2020 - 03/2004
3Tn antigenIBA
10/2018 - 07/2013
2P-SelectinIBA
01/2020 - 05/2013
2SelectinsIBA
01/2020 - 05/2013
2C-Type Lectins (C-Type Lectin)IBA
01/2019 - 07/2013
2Insulin (Novolin)FDA Link
10/2018 - 07/2009
2LectinsIBA
05/2015 - 04/2007
2GlycoconjugatesIBA
12/2014 - 04/2007
2AntigensIBA
07/2013 - 04/2012
2Phenobarbital (Luminal)FDA Link
05/2013 - 03/2013
2Monoclonal AntibodiesIBA
04/2012 - 02/2002
2DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)IBA
01/2010 - 03/2006
2DNA (Deoxyribonucleic Acid)IBA
06/2007 - 03/2004
2Hormones (Hormone)IBA
03/2006 - 02/2002
1Neuraminidase (Sialidase)IBA
01/2020
1Sialyl Lewis X AntigenIBA
01/2020
1EpitopesIBA
01/2020
1PronaseIBA
01/2020
1afimoxifene (hydroxytamoxifen)IBA
01/2019
1Indicators and Reagents (Reagents)IBA
10/2018
1EnzymesIBA
10/2018
1CateninsIBA
09/2016
1NucleolinIBA
05/2015
1cadherin 5IBA
03/2015
1Shiga Toxin 2IBA
03/2015
1Blood Group Antigens (Blood Groups)IBA
12/2014
1Immunoglobulin M (IgM)IBA
12/2014
1ABO Blood-Group SystemIBA
12/2014
1Oxygen (Dioxygen)IBA
11/2014
1Evans Blue (Blue, Evans)FDA Link
09/2013
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
09/2013
1Transcription Factors (Transcription Factor)IBA
03/2013
1Differentiation AntigensIBA
03/2013
1Keratin-14 (Keratin 14)IBA
03/2013
1Formaldehyde (Formol)FDA Link
03/2013
1ParaffinIBA
03/2013
1CarbohydratesIBA
03/2013
1ferric oxide (iron oxide)IBA
04/2012
1Contrast MediaIBA
04/2012
1GasesIBA
10/2011
1OsteopontinIBA
05/2010
1Keratins (Keratin)IBA
07/2009
1Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA
07/2009
1Codon (Codons)IBA
06/2007
1AntibodiesIBA
04/2007
1TIE-2 Receptor (Receptor, TIE 2)IBA
06/2006
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
06/2006
1CytokinesIBA
03/2006
1Messenger RNA (mRNA)IBA
03/2006
1Calcium IonophoresIBA
03/2006

Therapy/Procedure

2Therapeutics
01/2018 - 06/2007
2Ligation
11/2012 - 06/2006
1Transplantation
11/2012
1Quantum Dots (Quantum Dot)
04/2012